Paul R Michl
Examiner (ID: 15839)
Most Active Art Unit | 1505 |
Art Unit(s) | 1201, 1714, 1503, 1509, 3502, 2899, 1506, 1505, 1511, 3305 |
Total Applications | 2093 |
Issued Applications | 1688 |
Pending Applications | 51 |
Abandoned Applications | 343 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18019099
[patent_doc_number] => 20220370598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Vaccines Against Coronavirus and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 17/662141
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662141
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662141 | Vaccines Against Coronavirus and Methods of Use | May 4, 2022 | Pending |
Array
(
[id] => 17988905
[patent_doc_number] => 20220354942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => ATTENUATING VIRAL MUTATIONS IN PROTEIN GENES
[patent_app_type] => utility
[patent_app_number] => 17/737991
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737991 | ATTENUATING VIRAL MUTATIONS IN PROTEIN GENES | May 4, 2022 | Pending |
Array
(
[id] => 17929792
[patent_doc_number] => 20220324917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => RECOMBINANT RSV LIVE VACCINE STRAIN AND THE PREPARING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/717504
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717504 | RECOMBINANT RSV LIVE VACCINE STRAIN AND THE PREPARING METHOD THEREOF | Apr 10, 2022 | Pending |
Array
(
[id] => 17990175
[patent_doc_number] => 20220356212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => MODIFIED SPIKE PROTEIN AND METHOD OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/705090
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705090 | MODIFIED SPIKE PROTEIN AND METHOD OF TREATMENT | Mar 24, 2022 | Pending |
Array
(
[id] => 17895450
[patent_doc_number] => 20220305112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => NOVEL METHODS AND USES
[patent_app_type] => utility
[patent_app_number] => 17/680433
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680433 | NOVEL METHODS AND USES | Feb 24, 2022 | Pending |
Array
(
[id] => 17776567
[patent_doc_number] => 20220242916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Amino Acid Sequence Derived from Sars-Cov-2 and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/578049
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578049
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578049 | Amino Acid Sequence Derived from Sars-Cov-2 and Use Thereof | Jan 17, 2022 | Pending |
Array
(
[id] => 17564411
[patent_doc_number] => 20220128560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => HIGH THROUGHOUT IMMUNOASSAYS AND METHODS FOR THE DETECTION OF SARS-COV-2 ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/513538
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513538
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513538 | HIGH THROUGHOUT IMMUNOASSAYS AND METHODS FOR THE DETECTION OF SARS-COV-2 ANTIGENS | Oct 27, 2021 | Pending |
Array
(
[id] => 17441901
[patent_doc_number] => 20220062406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/460026
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460026 | IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF | Aug 26, 2021 | Pending |
Array
(
[id] => 17400027
[patent_doc_number] => 20220042117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
[patent_app_type] => utility
[patent_app_number] => 17/393742
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393742 | COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) | Aug 3, 2021 | Pending |
Array
(
[id] => 17412792
[patent_doc_number] => 20220047696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => ANTI-CORONAVIRUS VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/389724
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389724 | ANTI-CORONAVIRUS VACCINES | Jul 29, 2021 | Pending |
Array
(
[id] => 17357182
[patent_doc_number] => 20220017978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => VIROFIND: A NOVEL PLATFORM FOR DETECTION AND DISCOVERY OF THE ENTIRE VIROGENOME IN CLINICAL SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/305796
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305796 | VIROFIND: A NOVEL PLATFORM FOR DETECTION AND DISCOVERY OF THE ENTIRE VIROGENOME IN CLINICAL SAMPLES | Jul 13, 2021 | Pending |
Array
(
[id] => 17358041
[patent_doc_number] => 20220018837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Method for the Detection of Surface-Mounted Biological Materials and Pathogens
[patent_app_type] => utility
[patent_app_number] => 17/369691
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369691 | Method for the Detection of Surface-Mounted Biological Materials and Pathogens | Jul 6, 2021 | Pending |
Array
(
[id] => 17387044
[patent_doc_number] => 20220034896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHODS FOR QUANTITATIVE ANALYSIS OF ONE OR MORE BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 17/368711
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368711
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368711 | METHODS FOR QUANTITATIVE ANALYSIS OF ONE OR MORE BIOMARKERS | Jul 5, 2021 | Pending |
Array
(
[id] => 17035173
[patent_doc_number] => 20210252131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/242979
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242979
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242979 | COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES | Apr 27, 2021 | Pending |
Array
(
[id] => 17170333
[patent_doc_number] => 20210324003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => SIV ENVELOPE TRIMER
[patent_app_type] => utility
[patent_app_number] => 17/231415
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231415 | SIV ENVELOPE TRIMER | Apr 14, 2021 | Pending |
Array
(
[id] => 17036686
[patent_doc_number] => 20210253644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => CAPSID-MODIFIED, RAAV3 VECTOR COMPOSITIONS AND METHODS OF USE IN GENE THERAPY OF HUMAN LIVER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/132607
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/132607 | CAPSID-MODIFIED, RAAV3 VECTOR COMPOSITIONS AND METHODS OF USE IN GENE THERAPY OF HUMAN LIVER CANCER | Dec 22, 2020 | Pending |
Array
(
[id] => 17546734
[patent_doc_number] => 20220118075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => HANSENULA ENGINEERING FUNGI EFFICIENTLY EXPRESSING CA10 VIRUS-LIKE PARTICLES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/299520
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299520 | HANSENULA ENGINEERING FUNGI EFFICIENTLY EXPRESSING CA10 VIRUS-LIKE PARTICLES AND USE THEREOF | Sep 2, 2020 | Pending |
Array
(
[id] => 17673024
[patent_doc_number] => 20220186191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => SERUM-FREE MEDIUM FOR AVIAN VACCINE PRODUCTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/414759
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414759 | SERUM-FREE MEDIUM FOR AVIAN VACCINE PRODUCTION AND USES THEREOF | Jan 15, 2020 | Pending |
Array
(
[id] => 17428713
[patent_doc_number] => 20220056421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => A METHOD FOR DEPLETION OR REMOVAL OF ENDOTOXIN FROM AN ENDOTOXIN-CONTAINING SOURCE OR POTENTIALLY ENDOTOXIN-CONTAINING SOURCE
[patent_app_type] => utility
[patent_app_number] => 17/312756
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312756 | A METHOD FOR DEPLETION OR REMOVAL OF ENDOTOXIN FROM AN ENDOTOXIN-CONTAINING SOURCE OR POTENTIALLY ENDOTOXIN-CONTAINING SOURCE | Dec 15, 2019 | Pending |
Array
(
[id] => 17441904
[patent_doc_number] => 20220062409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => HETEROLOGOUS PRIME BOOST VACCINE COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/413203
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413203
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413203 | HETEROLOGOUS PRIME BOOST VACCINE COMPOSITIONS AND METHODS | Dec 12, 2019 | Pending |